• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

PathAI and Google Cloud Partner to Advance AI-Powered Pathology for Biopharma and Labs

by Fred Pennic 04/16/2024 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print
PathAI Lands $60M to Accelerate AI-Powered Pathology Platform

What You Should Know: 

– PathAI, a leading force in AI-powered pathology, has joined forces with Google Cloud at the Bio-IT World Conference & Expo to accelerate the integration of AI and digital pathology workflows within biopharmaceutical companies and anatomic pathology (AP) labs.

– By streamlining workflows, expediting data processing, and enabling the development of more precise AI models, this collaboration has the potential to revolutionize the field of pathology and accelerate the development of life-saving treatments.

PathAI’s AISight: A Central Hub for AI-Powered Pathology

At the heart of this collaboration lies PathAI’s AISight Intelligent Image Management System (IMS). This AI-native platform acts as a central hub, seamlessly integrating PathAI’s own algorithms and those from third-party developers. This consolidated approach offers researchers and pathologists a unified platform for image analysis, with direct access to powerful tools for biomarker quantification. These tools have the potential to streamline lab operations, enhance disease staging accuracy, and improve scoring efficiency.

Scaling AISight with Google Cloud’s Infrastructure

By leveraging Google Cloud’s robust infrastructure, PathAI plans to significantly expand the reach of AISight. This will enable biopharma companies and AP labs around the world to benefit from the platform’s capabilities. The partnership will involve integrating AISight with Google Cloud’s infrastructure and AI suite, offering several key advantages:

  • Faster Adoption of Precision Medicine: Google Cloud’s infrastructure empowers PathAI to rapidly scale AISight’s digital pathology capabilities globally. This translates to better-equipped labs and researchers, enabling them to process massive datasets (petabytes) crucial for large-scale biomarker discovery and clinical studies. Ultimately, these advancements will pave the way for faster development of targeted therapies for patients.
  • Customization and Tailored AI Solutions: The integration of Google Cloud’s cutting-edge AI tools within AISight empowers users to develop customized solutions and deploy novel AI models specifically tailored to their unique research needs. This flexibility allows researchers to tackle a wider range of challenges within the field of pathology.

“Bio-IT World is where pioneers convene to address the industry’s most significant challenges, including how to leverage massive scale data from biological and clinical studies to accelerate the discovery and development of transformative new therapies for patients. PathAI partners across the drug development paradigm, firstly with biopharma by enabling the development of new insights and diagnostics and supporting global clinical trials through PathAI’s AISight Clinical Trials platform, trial-ready algorithms, and Good Laboratory Practice (GLP) and Good Clinical Practice (GCP) compliant laboratory; and also with AP labs ensuring scaled access to algorithms through AISight,” said Dr. Andy Beck, CEO and co-founder of PathAI. “Our partnership with Google Cloud helps us transform our capabilities to accelerate adoption of these powerful tools and ultimately reshape how disease is understood and treated.”

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Artificial Intelligence, Digital Pathology

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Interview

Reach7 Diabetes Studios Founder Chun Yong on Reimagining Chronic Care with a Concierge Medical Model

Most-Read

Bayer Exits Radiology AI Market, Discontinuing Calantic and Blackford

Bayer Exits Radiology AI Market, Discontinuing Calantic and Blackford

Oracle Health Launches AI Center of Excellence for Healthcare

Oracle Health Launches AI Center of Excellence for Healthcare

Particle Health Addresses Integration to Epic Data Despite Dispute

US Court Allows Particle’s Antitrust Claims Against Epic to Proceed

Epic Launches Comet: A New AI Platform to Predict Patient Health Journeys

Epic Launches Comet: A New AI Platform to Predict Patient Health Journeys

Preparing for the ‘Big Beautiful Bill’: How Digitization Can Streamline Medicaid Eligibility & Social Care Delivery

Preparing for the ‘Big Beautiful Bill’: How Digitization Can Streamline Medicaid Eligibility & Social Care Delivery

Evernorth Health Services Invests $3.5B in Shields Health Solutions

Evernorth Health Services Invests $3.5B in Shields Health Solutions

KLAS Report: Oracle Health Faces Customer Losses and Declining Satisfaction

KLAS Report: Oracle Health Faces Customer Losses and Declining Satisfaction

Tempus AI Acquires Digital Pathology Leader Paige for $81.25M

M&A:Tempus AI Acquires Digital Pathology Leader Paige for $81.25M

Mira Launches Ultra4™, the First At-Home Hormone Monitor with Lab-Quality Insights

Femtech: Mira Launches Ultra4™, the First At-Home Hormone Monitor with Lab-Quality Insights

How Healthcare CIOs Can Solve the Unstructured Data Crisis and Reduce Storage Costs

How Healthcare CIOs Can Solve the Unstructured Data Crisis and Reduce Storage Costs

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |